ALK inhibitors, resistance development, clinical trials von Rothenstein, J M, Chooback, N

Volltext

Managing treatment-related adverse events associated with Alk inhibitors von Rothenstein, J M, Letarte, N

Volltext

Recent Advances in Nano-Enabled Seed Treatment Strategies for Sustainable Agriculture: Challenges, Risk Assessment, and Future Perspectives von Shelar, Amruta, Nile, Shivraj Hariram, Singh, Ajay Vikram, Rothenstein, Dirk, Bill, Joachim, Xiao, Jianbo, Chaskar, Manohar, Kai, Guoyin, Patil, Rajendra

Volltext

Attentional modulation and selection--an integrated approach von Rothenstein, Albert L, Tsotsos, John K

Volltext

Rechtzeitiger Zertifikateankauf von Rickels, Wilfried, Rothenstein, Roland

Volltext

Perspectives on treatment advances for stage III locally advanced unresectable non-small-cell lung cancer von Cheema, P K, Rothenstein, J, Melosky, B, Brade, A, Hirsh, V

Volltext

Genetically Induced In Situ‐Poling for Piezo‐Active Biohybrid Nanowires von Kilper, Stefan, Jahnke, Timotheus, Aulich, Marc, Burghard, Zaklina, Rothenstein, Dirk, Bill, Joachim

Volltext

Real-world benefit of nivolumab in a Canadian non-small-cell lung cancer cohort von Juergens, R A, Mariano, C, Jolivet, J, Finn, N, Rothenstein, J, Reaume, M N, Faghih, A, Labbé, C, Owen, S, Shepherd, F A, Villeneuve, J, Romeyer, F, Pettersson, F, Butts, C

Volltext

Procure, Bank, Release: Carbon Removal Certificate Reserves to Manage Carbon Prices on the Path to Net-Zero von Rickels, Wilfried, Rothenstein, Roland, Schenuit, Felix, Fridahl, Mathias

Volltext

Aquatic toxicity of triclosan von Orvos, David R., Versteeg, Donald J., Inauen, Josef, Capdevielle, Marie, Rothenstein, Arthur, Cunningham, Virginia

Volltext

Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC von Antonia, Scott J, Villegas, Augusto, Daniel, Davey, Vicente, David, Murakami, Shuji, Hui, Rina, Kurata, Takayasu, Chiappori, Alberto, Lee, Ki H, de Wit, Maike, Cho, Byoung C, Bourhaba, Maryam, Quantin, Xavier, Tokito, Takaaki, Mekhail, Tarek, Planchard, David, Kim, Young-Chul, Karapetis, Christos S, Hiret, Sandrine, Ostoros, Gyula, Kubota, Kaoru, Gray, Jhanelle E, Paz-Ares, Luis, de Castro Carpeño, Javier, Faivre-Finn, Corinne, Reck, Martin, Vansteenkiste, Johan, Spigel, David R, Wadsworth, Catherine, Melillo, Giovanni, Taboada, Maria, Dennis, Phillip A, Özgüroğlu, Mustafa

Volltext

Durvalumab after Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer von Antonia, Scott J, Villegas, Augusto, Daniel, Davey, Vicente, David, Murakami, Shuji, Hui, Rina, Yokoi, Takashi, Chiappori, Alberto, Lee, Ki H, de Wit, Maike, Cho, Byoung C, Bourhaba, Maryam, Quantin, Xavier, Tokito, Takaaki, Mekhail, Tarek, Planchard, David, Kim, Young-Chul, Karapetis, Christos S, Hiret, Sandrine, Ostoros, Gyula, Kubota, Kaoru, Gray, Jhanelle E, Paz-Ares, Luis, de Castro Carpeño, Javier, Wadsworth, Catherine, Melillo, Giovanni, Jiang, Haiyi, Huang, Yifan, Dennis, Phillip A, Özgüroğlu, Mustafa

Volltext

Management of egfr tki-induced dermatologic adverse events von Melosky, B, Leighl, N B, Rothenstein, J, Sangha, R, Stewart, D, Papp, K

Volltext

Isolation of ZnO-Binding 12-mer Peptides and Determination of Their Binding Epitopes by NMR Spectroscopy von Rothenstein, Dirk, Claasen, Birgit, Omiecienski, Beatrice, Lammel, Patricia, Bill, Joachim

Volltext

Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC von Socinski, Mark A, Jotte, Robert M, Cappuzzo, Federico, Orlandi, Francisco, Stroyakovskiy, Daniil, Nogami, Naoyuki, Rodríguez-Abreu, Delvys, Moro-Sibilot, Denis, Thomas, Christian A, Barlesi, Fabrice, Finley, Gene, Kelsch, Claudia, Lee, Anthony, Coleman, Shelley, Deng, Yu, Shen, Yijing, Kowanetz, Marcin, Lopez-Chavez, Ariel, Sandler, Alan, Reck, Martin

Volltext

Copyright callouts and the promise of creator-driven platform governance von Hallinan, Blake, Reynolds, C. J, Rothenstein, Omer

Volltext

Perspectives on treatment advances for stage III locally advanced unresectable non-small-cell lung cancer von Cheema, P. K., Rothenstein, J., Melosky, B., Brade, A., Hirsh, V.

Volltext

A nomogram to predict “pure” vs. “mixed” uric acid urinary stones von Zieber, Liran, Creiderman, Gherman, Krenawi, Muhammad, Rothenstein, Daniel, Enikeev, Dmitry, Ehrlich, Yaron, Lifshitz, David

Volltext

Phase II Trial of Atezolizumab As First-Line or Subsequent Therapy for Patients With Programmed Death-Ligand 1-Selected Advanced Non-Small-Cell Lung Cancer (BIRCH) von Peters, Solange, Gettinger, Scott, Johnson, Melissa L, Jänne, Pasi A, Garassino, Marina C, Christoph, Daniel, Toh, Chee Keong, Rizvi, Naiyer A, Chaft, Jamie E, Carcereny Costa, Enric, Patel, Jyoti D, Chow, Laura Q M, Koczywas, Marianna, Ho, Cheryl, Früh, Martin, van den Heuvel, Michel, Rothenstein, Jeffrey, Reck, Martin, Paz-Ares, Luis, Shepherd, Frances A, Kurata, Takayasu, Li, Zhengrong, Qiu, Jiaheng, Kowanetz, Marcin, Mocci, Simonetta, Shankar, Geetha, Sandler, Alan, Felip, Enriqueta

Volltext

Teprasiran, a Small Interfering RNA, for the Prevention of Acute Kidney Injury in High-Risk Patients Undergoing Cardiac Surgery: A Randomized Clinical Study von Thielmann, Matthias, Corteville, David, Szabo, Gabor, Swaminathan, Madhav, Lamy, Andre, Lehner, Lukas J., Brown, Craig D., Noiseux, Nicolas, Atta, Mohamed G., Squiers, Elizabeth C., Erlich, Shai, Rothenstein, Daniel, Molitoris, Bruce, Mazer, C. David

Volltext